The drug’s beginnings, according to the two former students there to see them, were quite humble. About a decade ago, Justin Klee and Josh Cohen …
Jeffrey Marrazzo, CEO of gene therapy developer Spark Therapeutics, will step down as head of the company he co-founded almost nine years ago, steered to …
Dive Brief: Bluebird bio will need to wait longer for a decision from the Food and Drug Administration on approval of two gene therapies it …
Melanoma is one of the fastest growing malignant cancers in China, increasing at an annual rate of 3-5 percent, which makes it one of the …
Innovent’s IBI101, is the first OX40-targeted molecule to receive IND approval in China Innovent Biologics, a world-class China-based biopharmaceutical company that develops and intends to …
